Current Diabetes Reports

Papers
(The median citation count of Current Diabetes Reports is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk105
Diabetes Complications in Racial and Ethnic Minority Populations in the USA105
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease83
Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus66
Artificial Intelligence in Current Diabetes Management and Prediction64
Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema59
Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment43
Adipose Tissue Inflammation and Cardiovascular Disease: An Update39
Genetics of Type 2 Diabetes: Implications from Large-Scale Studies39
Periodic and Intermittent Fasting in Diabetes and Cardiovascular Disease37
Retinal Neurodegeneration in Diabetes: an Emerging Concept in Diabetic Retinopathy37
The Use of Diabetes Technology to Address Inequity in Health Outcomes: Limitations and Opportunities34
Genetic Studies of Gestational Diabetes and Glucose Metabolism in Pregnancy33
PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine31
The Financial Impact of an Inpatient Diabetes Management Service31
Association Between Diabetes, Diabetic Retinopathy, and Glaucoma31
Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review30
Pancreas-on-a-Chip Technology for Transplantation Applications30
Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications29
The Prevalence of Diabetic Microvascular Complications in China and the USA27
Social Determinants of Health, Race, and Diabetes Population Health Improvement: Black/African Americans as a Population Exemplar27
Social Determinants of Poor Management of Type 2 Diabetes Among the Insured27
Management of Complications and Vision Loss from Proliferative Diabetic Retinopathy26
Efficacy of Ketogenic Diets on Type 2 Diabetes: a Systematic Review25
The Impact of Meal Timing on Risk of Weight Gain and Development of Obesity: a Review of the Current Evidence and Opportunities for Dietary Intervention24
Diabetes in People with HIV24
Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear21
Sleep Apnea and Cardiovascular Disease20
Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad20
Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efficacy and Economic Impacts20
Diabetes Risk and Control in Multi-ethnic US Immigrant Populations20
Predicting and Preventing Acute Care Re-Utilization by Patients with Diabetes19
Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism19
Brain Health in Children with Type 1 Diabetes: Risk and Protective Factors19
A Model of Adolescent Sleep Health and Risk for Type 2 Diabetes19
Lipodystrophy for the Diabetologist—What to Look For18
Prevalence of Diabetes in Patients with Hyperuricemia and Gout: A Systematic Review and Meta-analysis18
Use of Machine Learning Approaches in Clinical Epidemiological Research of Diabetes18
Cardiometabolic Morbidity and Mortality with Smoking Cessation, Review of Recommendations for People with Diabetes and Obesity18
Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes18
The Impact of COVID-19 on Diabetic Retinopathy Monitoring and Treatment17
Type 1 Diabetes, Sleep, and Hypoglycemia17
Pediatric Diabetic Retinopathy: Updates in Prevalence, Risk Factors, Screening, and Management16
Young Children with Type 1 Diabetes: Recent Advances in Behavioral Research16
Advances, Challenges, and Cost Associated with Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes16
CGM in the Hospital: Is It Ready for Prime Time?16
Sleep Apnea, Obesity, and Diabetes — an Intertwined Trio15
Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms15
Novel Treatments for Diabetic Macular Edema and Proliferative Diabetic Retinopathy15
Machine Learning Models for Inpatient Glucose Prediction15
COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study15
Body Composition Methods in Adults with Type 2 Diabetes or at Risk for T2D: a Clinical Review14
Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy14
Sleep Extension: A Potential Target for Obesity Treatment14
Does Weight Loss Improve Clinical Outcomes in Overweight and Obese Patients with Heart Failure?13
Review of Intravenous and Subcutaneous Electronic Glucose Management Systems for Inpatient Glycemic Control13
Autoimmune Inflammation and Insulin Resistance: Hallmarks So Far and Yet So Close to Explain Diabetes Endotypes13
Caring for Hospitalized Patients with Diabetes Mellitus, Hyperglycemia, and COVID-19: Bridging the Remaining Knowledge Gaps13
Safety and Efficacy of Inpatient Diabetes Management with Non-insulin Agents: an Overview of International Practices13
Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease13
Value of Patient-Centered Glycemic Control in Patients with Type 2 Diabetes12
Role of the Autonomic Nervous System in the Hemodynamic Response to Hyperinsulinemia—Implications for Obesity and Insulin Resistance12
The Role of Ultra-Widefield Fundus Imaging and Fluorescein Angiography in Diagnosis and Treatment of Diabetic Retinopathy12
Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence12
The Clash of Two Epidemics: the Relationship Between Opioids and Glucose Metabolism11
The β-Cell Genomic Landscape in T1D: Implications for Disease Pathogenesis11
Friend or Foe: a Narrative Review of the Impact of Diabetes Technology on Sleep11
Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost11
The Relationship Between Executive Functioning, Type 1 Diabetes Self-Management Behaviors, and Glycemic Control in Adolescents and Young Adults11
The Role of Programmed Death-1 in Type 1 Diabetes11
Patient-Centered Diabetes Care of Cancer Patients10
Multi-level Diabetes Prevention and Treatment Interventions for Native People in the USA and Canada: a Scoping Review10
Cellular Senescence in Obesity and Associated Complications: a New Therapeutic Target10
The Diabetes-Cardiovascular Connection in Women: Understanding the Known Risks, Outcomes, and Implications for Care10
Barriers and Facilitators to Diabetes Device Adoption for People with Type 1 Diabetes10
Managing Patients Undergoing Orthopedic Surgery to Improve Glycemic Outcomes10
Cardiovascular Risk Management in Type 1 Diabetes9
Integrated Behavioral Interventions for Adults with Comorbid Obesity and Depression: a Systematic Review9
Content Validity of Patient-Reported Outcome Measures Developed for Assessing Health-Related Quality of Life in People with Type 2 Diabetes Mellitus: a Systematic Review9
The Value of Measuring Diabetes Burnout9
Toward a New Staging System for Diabetic Retinopathy Using Wide Field Swept-Source Optical Coherence Tomography Angiography9
Mobile Health Technology in the Primary Prevention of Type 2 Diabetes: a Systematic Review9
Implementation of Psychosocial Screening into Diabetes Clinics: Experience from the Type 1 Diabetes Exchange Quality Improvement Network9
A Question of Tolerance—Antigen-Specific Immunotherapy for Type 1 Diabetes8
Racial Disparities and Cardiometabolic Risk: New Horizons of Intervention and Prevention8
Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists8
Mindfulness-Based Interventions: Focus on Pediatric Type 1 and Type 2 Diabetes7
Implementation of Continuous Glucose Monitoring in Critical Care: A Scoping Review7
Is Diabetes Mellitus a Predisposing Factor for Helicobacter pylori Infections?7
Role of Glucose Metabolism and Mitochondrial Function in Diabetic Kidney Disease7
Sarcopenic Obesity and Cardiometabolic Health and Mortality in Older Adults: a Growing Health Concern in an Ageing Population7
Molecular Aspects in the Potential of Vitamins and Supplements for Treating Diabetic Neuropathy7
Telehealth for the Management of Diabetes in Pregnancy7
Consumption of Non-nutritive Sweeteners and Risk for Type 2 Diabetes: What Do We Know, and Not?7
Suicide Risk in Youth and Young Adults with Type 1 Diabetes: a Review of the Literature and Clinical Recommendations for Prevention7
Immunological Monitoring in Beta Cell Replacement: Towards a Pathophysiology-Guided Implementation of Biomarkers7
Metagenomics to Identify Pathogens in Diabetic Foot Ulcers and the Potential Impact for Clinical Care6
Assessing Glycemic Control Using CGM for Women with Diabetes in Pregnancy6
Implementation of Technology-Delivered Diabetes Self-care Interventions in Clinical Care: a Narrative Review6
Novel Immunomodulatory Approaches for Porcine Islet Xenotransplantation6
Metabolic Syndrome and Vascular-Associated Cognitive Impairment: a Focus on Preclinical Investigations6
SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis6
Emergency Glucagon: a Focused Review of Psychosocial Experiences of Rescue Drugs for Type 1 Diabetes6
The T1D Index: Implications of Initial Results, Data Limitations, and Future Development6
The Role of Aspirin for Preeclampsia Prevention in Women with Diabetes6
0.029130935668945